1,051 results on '"Waters, David D."'
Search Results
102. Effects of High-Dose Atorvastatin on Cerebrovascular Events in Patients With Stable Coronary Disease in the TNT (Treating to New Targets) Study
103. Effects of Statin Therapy on the Development and Progression of Heart Failure: Mechanisms and Clinical Trials
104. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.
105. Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease
106. Comparison of acute rest myocardial perfusion imaging and serum markers of myocardial injury in patients with chest pain syndromes
107. Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis
108. On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study
109. 82 - Anomalías cardiovasculares en personas infectadas por el VIH
110. 82 - Cardiovascular Abnormalities in HIV-Infected Individuals
111. Notes From Cardiology Clinic: Health Care Heroine, Unpaid and Unappreciated
112. Inflammation in Cardiovascular Disease: From Basic Concepts to Clinical Application
113. Erratum to “Notes From Cardiology Clinic: The Patients We Dislike”
114. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
115. When Diastole Lets You Down: Clinical Relevance of a Widened Pulse Pressure
116. Notes From Cardiology Clinic: The Patients We Dislike
117. Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib
118. WITHDRAWN: Notes From Cardiology Clinic: The Patients We Dislike
119. Treatment of Cardiovascular Manifestations of HIV
120. Contributors
121. Hormone therapy and antioxidant vitamins do not improve endothelial vasodilator function in postmenopausal women with established coronary artery disease: a substudy of the Women's Angiographic Vitamin and Estrogen (WAVE) trial
122. Safety of High-Dose Atorvastatin Therapy
123. The SPARCL study: extending the indications of statin therapy for stroke?
124. Safety of dipyridamole testing in 73,806 patients: The Multicenter Dipyridamole Safety Study
125. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
126. Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis
127. Intensive Lipid Lowering with Atorvastatin in Coronary Disease
128. The inflammatory etiology of unstable angina
129. Quantitation of myocardial dysfunction in ischemic heart disease by echocardiographic endocardial surface mapping: correlation with hemodynamic status
130. Vitamins and Hormone Therapy for Coronary Atherosclerosis
131. PRINCE’s prospects: Statins, inflammation, and coronary risk
132. Management of a Patient With Angina Pectoris*
133. Contributors
134. Clinical and Angiographic Characteristics of Exertion-Related Acute Myocardial Infarction
135. Comments: Praluent (Alirocumab)-Induced Renal Injury
136. High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)
137. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
138. Comparison of Cardiac Troponin I, Creatine Kinase-MB, and Myoglobin for Detection of Acute Ischemic Myocardial Injury in a Swine Model
139. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons.
140. Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart disease
141. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on Cardiac Catheterization Laboratory Standards : A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents endorsed by the American Heart Association and the Diagnostic and Interventional Catheterization Committee of the Council on Clinical Cardiology of the AHA
142. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
143. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial†
144. Differential phase acoustic microscope for micro-NDE
145. Synergy between intracoronary stenting and abciximab in improving angiographic and clinical outcomes of primary angioplasty in acute myocardial infarction
146. Short- and medium-term outcome differences in women and men after primary percutaneous transluminal mechanical revascularization for acute myocardial infarction
147. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability
148. Lipids, inflammation, and chronic kidney disease: a SHARP perspective
149. Taking Hockey to Heart: Potential Coronary Risks of Watching Exciting Games
150. Will Colchicine Soon Be Part of Primary and Secondary Cardiovascular Prevention?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.